C-MER Medical Buys Back 160,000 Shares, Expands Treasury Stock to 23.36 Million

Bulletin Express07-23

Hong Kong–listed eye-care specialist C-MER Medical Holdings Limited disclosed a modest on-market share repurchase on 23 July 2026, trimming its outstanding share capital and marginally increasing treasury holdings.

Key transaction details • Date of repurchase: 23 July 2026 • Volume: 160,000 ordinary shares • Price range: HKD 0.94–0.96 per share, volume-weighted average of HKD 0.9469 • Aggregate consideration: HKD 0.15 million

Impact on share capital • Issued shares (excluding treasury) decreased to 1.20898 billion from 1.20914 billion, a reduction of 0.0132%. • Treasury shares rose to 23.36 million from 23.20 million, bringing total issued shares (including treasury) to 1.23234 billion—unchanged from the prior day.

Repurchase mandate utilisation • The current mandate, approved on 20 May 2026, allows the company to buy back up to 123.23 million shares. • C-MER Medical has so far utilised 0.13% of this limit (160,000 shares).

Regulatory considerations • In accordance with Hong Kong listing rules, C-MER Medical is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares until 22 August 2026.

The board confirmed that the repurchase complied with Main Board Rule 10.06 and that no changes have been made to the repurchase mandate’s explanatory statement filed on 23 April 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1189669252?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-23 20:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189669252","market":"hk","top_or_hot":-1,"title":"C-MER Medical Buys Back 160,000 Shares, Expands Treasury Stock to 23.36 Million","media":"Bulletin Express","content":"<p>Hong Kong–listed eye-care specialist C-MER Medical Holdings Limited disclosed a modest on-market share repurchase on 23 July 2026, trimming its outstanding share capital and marginally increasing treasury holdings.</p>\n<p>Key transaction details  \n• Date of repurchase: 23 July 2026  \n• Volume: 160,000 ordinary shares  \n• Price range: HKD 0.94–0.96 per share, volume-weighted average of HKD 0.9469  \n• Aggregate consideration: HKD 0.15 million</p>\n<p>Impact on share capital  \n• Issued shares (excluding treasury) decreased to 1.20898 billion from 1.20914 billion, a reduction of 0.0132%.  \n• Treasury shares rose to 23.36 million from 23.20 million, bringing total issued shares (including treasury) to 1.23234 billion—unchanged from the prior day.</p>\n<p>Repurchase mandate utilisation  \n• The current mandate, approved on 20 May 2026, allows the company to buy back up to 123.23 million shares.  \n• C-MER Medical has so far utilised 0.13% of this limit (160,000 shares).</p>\n<p>Regulatory considerations  \n• In accordance with Hong Kong listing rules, C-MER Medical is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares until 22 August 2026.</p>\n<p>The board confirmed that the repurchase complied with Main Board Rule 10.06 and that no changes have been made to the repurchase mandate’s explanatory statement filed on 23 April 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C-MER Medical Buys Back 160,000 Shares, Expands Treasury Stock to 23.36 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC-MER Medical Buys Back 160,000 Shares, Expands Treasury Stock to 23.36 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-23 20:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong–listed eye-care specialist C-MER Medical Holdings Limited disclosed a modest on-market share repurchase on 23 July 2026, trimming its outstanding share capital and marginally increasing treasury holdings.</p>\n<p>Key transaction details  \n• Date of repurchase: 23 July 2026  \n• Volume: 160,000 ordinary shares  \n• Price range: HKD 0.94–0.96 per share, volume-weighted average of HKD 0.9469  \n• Aggregate consideration: HKD 0.15 million</p>\n<p>Impact on share capital  \n• Issued shares (excluding treasury) decreased to 1.20898 billion from 1.20914 billion, a reduction of 0.0132%.  \n• Treasury shares rose to 23.36 million from 23.20 million, bringing total issued shares (including treasury) to 1.23234 billion—unchanged from the prior day.</p>\n<p>Repurchase mandate utilisation  \n• The current mandate, approved on 20 May 2026, allows the company to buy back up to 123.23 million shares.  \n• C-MER Medical has so far utilised 0.13% of this limit (160,000 shares).</p>\n<p>Regulatory considerations  \n• In accordance with Hong Kong listing rules, C-MER Medical is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares until 22 August 2026.</p>\n<p>The board confirmed that the repurchase complied with Main Board Rule 10.06 and that no changes have been made to the repurchase mandate’s explanatory statement filed on 23 April 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03309","symbol_name":"希玛医疗","start_time":0,"source_url":"","article_id":"1189669252","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189669252","pubTimestamp":1784809422,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong–listed eye-care specialist C-MER Medical Holdings Limited disclosed a modest on-market share repurchase on 23 July 2026, trimming its outstanding share capital and marginally increasing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03309":"希玛医疗"},"translate_title":"C-MER Medical 回购 16 万股股票，库存股增至 2336 万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03309":1},"content_text":"Hong Kong–listed eye-care specialist C-MER Medical Holdings Limited disclosed a modest on-market share repurchase on 23 July 2026, trimming its outstanding share capital and marginally increasing treasury holdings.\nKey transaction details  \n• Date of repurchase: 23 July 2026  \n• Volume: 160,000 ordinary shares  \n• Price range: HKD 0.94–0.96 per share, volume-weighted average of HKD 0.9469  \n• Aggregate consideration: HKD 0.15 million\nImpact on share capital  \n• Issued shares (excluding treasury) decreased to 1.20898 billion from 1.20914 billion, a reduction of 0.0132%.  \n• Treasury shares rose to 23.36 million from 23.20 million, bringing total issued shares (including treasury) to 1.23234 billion—unchanged from the prior day.\nRepurchase mandate utilisation  \n• The current mandate, approved on 20 May 2026, allows the company to buy back up to 123.23 million shares.  \n• C-MER Medical has so far utilised 0.13% of this limit (160,000 shares).\nRegulatory considerations  \n• In accordance with Hong Kong listing rules, C-MER Medical is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares until 22 August 2026.\nThe board confirmed that the repurchase complied with Main Board Rule 10.06 and that no changes have been made to the repurchase mandate’s explanatory statement filed on 23 April 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1189669252","isCrawlerRequest":true}